Bespak
Bespak introduced its new single-use nasal delivery device, Unidose Xtra.
The appliance delivers a liquid dosage between 100 – 150 micro litres into the nasal cavity.
Bespak says it will improve patient compliance because of tight particle distribution, which reduces variability from device to device.
“We have already had interest from a number of major pharmaceutical companies, and have two developments with such firms currently on-going over our nasal technology,” the company’s commercial director Ian Campbell told us.
He added that Bespak had discussed its platform with a number of firms at the conference in Paris.